Answers are grounded in this paper and cite their sources.
Clinical trial cohort analysis reveals Capgras syndrome clusters with broader delusional misidentifications and behavioral symptoms in Alzheimer's disease, indicating a complex neuropsychiatric...
Introduction Capgras syndrome (CS) is a recurrent and transient delusional misidentification disorder in which an individual is firmly convinced that a familiar person has been replaced by an identical impostor. The aim of the study was to evaluate neuropsychiatric characteristics of CS in a cohort of patients with Alzheimer’s disease (AD).Methods 150 participants [84 (56.0%) women, mean age 77.4 ± 7.5 years)] were collected within the Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer disease (CATIE-AD). According to the Neuropsychiatric Inventory, patients were classified into Capgras+ and Capgras−.Results Fifty-five (36.7%) AD patients were Capgras+. CS was strongly associated with other misidentification syndromes including phantom boarder (p < 0.001) and misidentification of places (p < 0.001). Moreover, Capgras+ were presented more frequently with agitation (p = 0.036), depressive (p = 0.018) and anxious (p = 0.004) symptoms, and aberrant motor behaviours (p = 0.020).Conclusions According to our findings, CS was not an ‘isolated’ phenomenon but rather a complex neuropsychiatric syndrome frequently associated with other misidentification syndromes and specific behavioural disturbances.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: